Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

666 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.
Lazzari L, Farina F, Lupo Stanghellini MT, Piemontese S, Marktel S, Mazzi B, Vago L, Milani R, Ferrario A, Bianchi B, Merli M, Ferreri AJM, Corti C, Peccatori J, Ruggeri A, Ciceri F. Lazzari L, et al. Among authors: merli m. Curr Res Transl Med. 2021 Oct;69(4):103313. doi: 10.1016/j.retram.2021.103313. Epub 2021 Sep 28. Curr Res Transl Med. 2021. PMID: 34598023 No abstract available.
Clinical predictors of outcome in MPN.
Passamonti F, Maffioli M, Merli M, Ferrario A, Caramazza D. Passamonti F, et al. Among authors: merli m. Hematol Oncol Clin North Am. 2012 Oct;26(5):1101-16. doi: 10.1016/j.hoc.2012.07.009. Epub 2012 Aug 28. Hematol Oncol Clin North Am. 2012. PMID: 23009940 Review.
Novel agents in indolent lymphomas.
Merli M, Ferrario A, Basilico C, Maffioli M, Caramazza D, Appio L, Arcaini L, Passamonti F. Merli M, et al. Ther Adv Hematol. 2013 Apr;4(2):133-48. doi: 10.1177/2040620712466865. Ther Adv Hematol. 2013. PMID: 23610620 Free PMC article.
Primary leptomeningeal CNS lymphoma presenting as bilateral facial nerve palsy.
Gastaldi M, Ferrario A, Basilico C, Merli M, Mauri M, Tibiletti MG, Passamonti F, Franciotta D, Bono G. Gastaldi M, et al. Among authors: merli m. J Neurol Sci. 2014 Sep 15;344(1-2):234-5. doi: 10.1016/j.jns.2014.06.036. Epub 2014 Jun 24. J Neurol Sci. 2014. PMID: 24996491 No abstract available.
Everolimus in diffuse large B-cell lymphomas.
Merli M, Ferrario A, Maffioli M, Arcaini L, Passamonti F. Merli M, et al. Future Oncol. 2015;11(3):373-83. doi: 10.2217/fon.14.264. Future Oncol. 2015. PMID: 25675120 Review.
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.
Ferrario A, Merli M, Basilico C, Maffioli M, Passamonti F. Ferrario A, et al. Among authors: merli m. Expert Opin Investig Drugs. 2017 Mar;26(3):367-373. doi: 10.1080/13543784.2017.1288213. Epub 2017 Feb 9. Expert Opin Investig Drugs. 2017. PMID: 28140696 Review.
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.
Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S. Storti S, et al. Among authors: merli f, merli m. Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10. Haematologica. 2018. PMID: 29748444 Free PMC article. Clinical Trial.
666 results